1. Introduction {#sec1}
===============

The global burden of cancer weighs more each day. Currently, there are more than 22 million cases in the world with more than half in developing countries \[[@B1], [@B2]\]. Togo, following the example of most countries in the WHO African region, has no data on the extent and global characteristics of cancer \[[@B3]\].

The aim of our study was to describe the epidemiological and histopathological aspects of cancers diagnosed in the laboratory of pathology of CHU-TOKOIN in Lomé, in order to promote the establishment of a cancer register in Togo. Togo is indeed a small country in the West African coast of 56600 km^2^ with 6,145,000 inhabitants. It has a population growth rate of 2.7% and life expectancy at birth is 54 years. The population is very young (60% under 20 years and only 3.1% over 64 years) and the seroprevalence rate of HIV passed from 6% in 2000 to 4.5% in 2004 \[[@B4]\]. The economy of the country relies on agriculture, breeding, and export of phosphate.

2. Materials and Methods {#sec2}
========================

This was a retrospective and descriptive study carried on all cancer cases diagnosed from January 1984 to December 2008 (25 years) in the only laboratory of pathology of Togo, located inside CHU-TOKOIN in Lomé (Togo). These cases were compiled from records of that laboratory. The study material consisted of biopsies and surgical specimens fixed in formalin at 10% and came from various medical structures in Togo. These samples were processed by conventional histological techniques. Studied variables were frequency, sex, age, cancer site, and its histological nature. For the distribution of different anatomical sites of cancers we used the international classification of diseases adopted by WHO in 2002 (ICD-10). Statistical processing and data analysis were performed by using SPSS software.

3. Results {#sec3}
==========

3.1. Epidemiological Aspects {#sec3.1}
----------------------------

We have collected during our study period 5251 cases of cancer histologically confirmed, with a yearly average of 210 cases. We observed a decrease of cancer incidence in the last ten years (from 1999 to 2008) with 163 cases yearly. Men were affected in 2565 cases and women in 2686 cases, representing, respectively, 48.8% and 51.2% of cases with a ratio of 0.9.

The average age of patients was 45.3 years with extremes of 10 days and 98 years. This average was 43.8 years for women and 46.9 years for men. [Figure 1](#fig1){ref-type="fig"} shows the distribution of cancers according to sex and age. The most affected age bracket was 45--54 years for women (21%) and over 64 years for men (23.2%).

The distribution of cancers by site and sex is presented in [Table 1](#tab1){ref-type="table"}, which shows a predominance of breast cancers (14.4%), non-Hodgkin lymphoma (7.8%) and nonmelanoma skin cancers (7.6%). This table shows also that in men, prostate cancer (12.9%), nonmelanoma skin cancer (10.4%) and stomach cancer (10.3%) predominated, while in women, it was breast cancer (27.1%), cervix cancer (11.2%), and non-Hodgkin lymphoma (6.3%) that were more observed.

Tables [2](#tab2){ref-type="table"} and [3](#tab3){ref-type="table"} show, respectively, the distribution of the different sites of cancer according to age for men and women.

3.2. Histopathological Aspects {#sec3.2}
------------------------------

The 5251 cases of cancer were subdivided in 3574 carcinomas (68.1%), 833 hematopoietic tissue cancers (15.9%), 581 sarcomas (11.0%), 143 embryonic and placental malignant tumors (2.7%), and 120 other histological types (2.3%) as shown in [Table 4](#tab4){ref-type="table"}.

3.3. Children Cancers (under 15 Years) {#sec3.3}
--------------------------------------

The children cancers were observed in 365 cases representing 7% of all cancers recorded, with a yearly average of 14.6 cases. Boys were affected in 218 cases and girls in 146 cases, with a sex ratio of 1.5. The average age of these children was 8.1 years old.

Histologically, we noted a predominance of lymphomas (219 cases, 60%) including 102 cases of Burkitt lymphoma, retinoblastoma (31 cases, 8.5%), and nephroblastoma (17 cases, 4.7%).

4. Discussion {#sec4}
=============

Our study focused on epidemiological and histopathological analysis of cancers diagnosed during 25 years in Togo. It brings together all histologically confirmed cases across the country because the laboratory of pathology of CHU-TOKOIN, is the only one in Togo for all requests of histopathological examination. So our study must put cancer in its epidemiological framework in Togo and constitute a basis for the establishment of a cancer register in our country.

We then observed during our study period 5251 cases of cancers proved histologically with a yearly average of 210 cases. This value is comparable to those observed in most African countries particularly Burkina Faso, but clearly inferior to those of western countries \[[@B1], [@B5], [@B6]\]. These differences are in part related to the unequal distribution of cancer throughout the world but also to the size of the populations investigated. They could also be explained by the weak frequentation of the health centers in developing countries, and where women are more affected by cancer. The sex ratio in our study is similar to those observed in Uganda, Algeria, and Brazil \[[@B1], [@B5]\]. This female predominance is even more pronounced in some countries such as Cameroon and Nigeria with a sex ratio of 0.7 \[[@B5], [@B7]\], contrary to the observations made in European countries or Asia where there is a clear male predominance \[[@B1], [@B8]\]. This female predominance of cancer in our countries is explained by the large proportion of breast and cervix cancers.

The average age of our patients is comparable to that of developing countries but lower than those observed in developed countries. This would be related to the longer life expectancy of these countries. The most common cancers for both sexes in our study (breast cancer, non-Hodgkin lymphoma, and nonmelanoma skin cancer) were different from those estimated by IARC Globocan where breast, cervix uteri, and prostate predominated \[[@B9]\]. Moreover Globocan estimated prostate and liver cancers the two main cancers in men. These estimations are different from our observations and may be due to the case of many patients who, after having wasted an invaluable time near the healers, consult the medical practitioner only at the final stage of their illness. For these cases, most practitioners had found any samples for histological confirmation useless. It was mainly the case of liver cancer that account only for 2.2% of cases (11th overall). This frequency of liver cancer in our study reflects a little the real impact of this cancer in Togo. The diagnosis of the disease is most often based on clinical findings, especially when patients come to a very advanced stage of their disease. So, the histological diagnosis of such patients does not appear in our records and this would let think that liver cancer is rare in Togo, compared to some African countries like Mali, Cameroon, and Senegal, where liver cancer represents respectively 42.1%, 38.2%, and 36.8% of recorded cancers and where it occupies the first rank \[[@B5]\]. Indeed, Africa is a region with high incidence of liver cancer, but with very large variations from one country to another \[[@B3], [@B5], [@B6]\]. The establishment of a cancer register will help to catch up these cases for a better cancer assessment in Togo. For women, breast and cervix uteri cancers were more frequent corroborating data from the literature \[[@B1], [@B5], [@B9]\]. In our study we observed a decrease of cancer incidence in the last ten years. This may be due to sensitization on cancer prevention. We have no data on the survival estimation from cancer as it was a retrospective laboratory work.

Histologically we noted a predominance of carcinomas as in the study of Goumbri-Lompo in Burkina Faso where carcinomas represented 75.5% of cases \[[@B6]\]. The non-Hodgkin lymphoma accounted for 12.6% of cases, a value exceeding that of world literature. Indeed, the non-Hodgkin lymphoma represents 2.9% of cancers worldwide, 3.9% of cancers in Africa, and 5.1% in Sub-Saharan Africa but with significant variations of the frequency from one country to another \[[@B1], [@B5]\]. The high incidence of non-Hodgkin lymphoma in some parts of Africa is linked to infectious causes including viral and parasitic infection implicated in the genesis of some of the non-Hodgkin lymphoma including Burkitt lymphoma \[[@B10], [@B11]\]. Burkitt lymphoma accounted in fact for the most common children cancer, followed by retinoblastoma and Wilms tumor, as in most African countries \[[@B12]--[@B14]\].

5. Conclusion {#sec5}
=============

Our retrospective study aimed to describe the epidemiological and histopathological aspects of cancers in Togo. It covered 5251 cases occurring at a mean age of 45.3 years with a slight female predominance. The most frequent cancers in this study were those of prostate for men and breast for women. For children, it was essentially Burkitt lymphoma and retinoblastoma. The high incidence of cancers in Togo shows the importance of this study and emphasizes on the necessity of the establishment of a cancer register, which is necessary to a national policy of prevention and fight against cancer in Togo.

![Distribution of cancers according to age and sex. \*unk: unknown.](JCE2011-319872.001){#fig1}

###### 

Distribution of cancers by site and sex.

  ICD-10     Site                           Male   \%     Female   \%     Both sexes   \%
  ---------- ------------------------------ ------ ------ -------- ------ ------------ ------
  C0--C06    Mouth                          80     3.1    39       1.5    119          2.3
  C07-C08    Salivary gland                 77     3.0    39       1.5    116          2.2
  C9--C14    Pharynx                        52     2      22       0.8    74           1.3
  C15        Oesophagus                     129    5.0    49       1.8    178          3.4
  C16        Stomach                        264    10.3   115      4.3    379          7.2
  C17        Small intestine                19     0.7    14       0.5    33           0.6
  C18--C21   Colon, rectum, anus            115    4.5    61       2.2    176          3.4
  C22        Liver                          74     2.9    42       1.6    116          2.2
  C23-C24    Gallbladder, and so forth.     3      0.1    5        0.2    8            0.2
  C25        Pancreas                       16     0.6    5        0.2    21           0.4
  C30-C31    Nose, sinuses, and so forth.   31     1.2    10       0.4    41           0.8
  C32        Larynx                         95     3.7    12       0.4    107          2.0
  C33-C34    Trachea, bronchus and lung     40     1.6    12       0.4    52           1.0
  C38        Pleura                         23     0.9    31       1.2    54           1.0
  C40-C41    Bone                           160    6.2    99       3.7    259          4.9
  C43        Melanoma of the skin           48     1.9    25       0.9    73           1.4
  C44        Other skin cancers             268    10.4   134      5.0    402          7.6
  C45        Mesothelioma                   2      0.0    5        0.2    7            0.2
  C46        Kaposi\'s sarcoma              92     3.6    133      5.0    225          4.3
  C49        Other soft tissue              13     0.5    14       0.5    27           0.5
  C50        Breast                         25     1.1    729      27.1   754          14.4
  C51        Vulva                          ---    ---    20       0.7    20           0.4
  C52        Vagina                         ---    ---    27       1.0    27           0.5
  C53        Cervix                         ---    ---    302      11.2   302          5.8
  C54        Uterus                         ---    ---    112      4.2    112          2.1
  C56        Ovary                          ---    ---    132      4.9    132          2.5
  C57        Fallopian tube                 ---    ---    3        0.1    3            0.1
  C58        Placenta                       ---    ---    43       1.6    43           0.8
  C60        Penis                          13     0.5    ---      ---    13           0.2
  C61        Prostate                       332    12.9   ---      ---    332          6.3
  C62        Testis                         21     0.8    ---      ---    21           0.4
  C64        Kidney                         29     1.1    22       0.8    51           1.1
  C65        Renal pelvis                   4      0.2    1        0.0    5            0.1
  C67        Bladder                        43     1.7    21       0.8    64           1.2
  C68        Ureter                         1      0.0    0        0.0    1            0.0
  C69        Eye                            70     2.7    62       23     132          2.5
  C70--C72   Brain, nervous system          2      0.1    4        0.1    6            0.1
  C73        Thyroid                        23     0.9    62       2.3    85           1.6
  C76        Other and unspecified          13     0.5    9        0.3    22           0.4
  C77--C80   Metastasis                     55     2.1    41       1.5    96           1.9
  C81        Hodgkin disease                62     2.4    30       1.1    92           1.8
  C82--C85   Non-Hodgkin Lymphoma           237    9.2    170      6.3    407          7.8
  C90        Myeloma                        5      0.2    1        0.0    6            0.1
  C91--C95   Leukaemia                      29     1.1    29       1.1    58           1.1
                                                                                       
             All sites                      2565   100    2686     100    5251         100

Nb\*\*: Number.

###### 

Distribution of cancers by site and age in men.

  ICD-10     Site                           Unk   0--14   15--24   25--34   35--44   45--54   55--64   65+   All    \%
  ---------- ------------------------------ ----- ------- -------- -------- -------- -------- -------- ----- ------ ------
  C0--C06    Mouth                          1     1       3        7        12       20       22       14    80     3.1
  C07-C08    Salivary gland                 1     6       10       12       12       9        16       11    77     3.0
  C9--C14    Pharynx                        1     3       4        3        6        12       7        16    52     5.2
  C16        Stomach                        8     1       9        16       48       64       44       74    264    10.3
  C17        Small intestine                0     1       5        2        3        0        4        4     19     0.7
  C18--C21   Colon, rectum, anus            0     3       5        12       25       31       20       19    176    4.5
  C22        Liver                          1     4       5        20       11       17       9        7     74     2.9
  C23-C24    Gallbladder, and so forth.     0     0       0        0        2        1        0        0     3      0.1
  C25        Pancreas                       0     0       1        2        2        2        6        3     16     0.6
  C30-C31    Nose, sinuses, and so forth.   1     1       5        2        3        6        5        8     31     1.2
  C32        Larynx                         1     0       0        4        16       38       25       11    95     3.7
  C33-C34    Trachea, bronchus and lung     0     0       3        4        7        13       5        8     40     1.6
  C38        Pleura                         0     0       2        2        1        6        6        6     23     0.9
  C40-C41    Bone                           2     51      21       17       15       25       10       19    160    6.2
  C43        Melanoma of the skin           0     0       0        7        11       8        8        14    48     1.9
  C44        Other skin cancers             5     4       4        66       50       48       30       31    268    10.4
  C45        Mesothelioma                   0     0       0        1        0        0        1        0     2      0.0
  C46        Kaposi\'s sarcoma              3     10      3        16       21       13       9        17    92     3.6
  C49        Other soft tissue              1     5       3        0        0        0        4        0     13     0.5
  C50        Breast                         0     0       0        2        4        5        2        12    25     1.1
  C60        Penis                          0     0       0        0        1        1        8        3     13     0.5
  C61        Prostate                       3     0       0        0        2        26       73       228   332    12.9
  C62        Testis                         0     6       3        2        1        3        2        4     21     0.8
  C64        Kidney                         0     11      5        2        0        3        5        3     29     1.1
  C65        Renal pelvis                   0     0       0        0        0        2        2        0     4      0.2
  C67        Bladder                        0     1       0        1        15       5        10       11    43     1.7
  C68        Ureter                         1     0       0        0        0        0        0        0     1      0.0
  C69        Eye                            1     24      9        7        11       7        7        4     70     2.7
  C70--C72   Brain, nervous system          0     0       0        1        0        1        0        0     2      0.1
  C73        Thyroid                        0     0       1        4        7        4        4        3     23     0.9
  C76        Other and unspecified          0     0       1        2        3        3        2        2     13     0.5
  C77--C80   Metastasis                     3     0       4        6        8        20       7        7     55     2.1
  C81        Hodgkin disease                0     23      17       9        7        3        2        1     62     2.4
  C82--C85   Non-Hodgkin Lymphoma           4     61      38       29       31       38       18       18    237    9.2
  C90        Myeloma                        0     0       0        1        0        2        2        0     5      0.2
  C91--C95   Leukaemia                      1     2       3        5        5        4        5        4     29     1.1
                                                                                                                    
             All sites                      39    219     195      268      353      482      413      596   2565   100

###### 

Distribution of cancers by site and age in women.

  ICD-10     Site                           Unk   0--14   15--24   25--34   35--44   45--54   55--64   65+   All    \%
  ---------- ------------------------------ ----- ------- -------- -------- -------- -------- -------- ----- ------ ------
  C0--C06    Mouth                          0     3       3        7        10       9        3        4     39     1.5
  C07-C08    Salivary gland                 1     2       6        9        7        5        2        8     39     1.5
  C9--C14    Pharynx                        0     1       2        6        2        3        3        4     22     0.8
  C15        Oesophagus                     0     0       2        6        7        8        16       10    49     1.8
  C16        Stomach                        0     0       5        4        14       30       23       39    115    4.3
  C17        Small intestine                0     3       1        4        2        3        0        1     14     0.5
  C18--C21   Colon, rectum, anus            0     1       6        8        11       12       9        14    61     2.2
  C22        Liver                          0     4       4        7        8        7        3        9     42     1.6
  C23-C24    Gallbladder, and so forth.     0     0       0        0        1        1        1        2     5      0.2
  C25        Pancreas                       0     0       0        1        0        2        0        2     5      0.2
  C30-C31    Nose, sinuses, and so forth.   0     1       2        0        3        1        3        0     10     0.4
  C32        Larynx                         0     1       0        0        3        1        1        6     12     0.4
  C33-C34    Trachea, bronchus and lung     1     1       0        0        2        4        1        3     12     0.4
  C38        Pleura                         1     0       1        2        4        4        6        13    31     1.2
  C40-C41    Bone                           1     21      17       13       8        8        10       21    99     3.7
  C43        Melanoma of the skin           0     0       0        3        5        6        8        3     25     0.9
  C44        Other skin cancers             1     0       6        25       17       20       27       38    134    5.0
  C45        Mesothelioma                   1     2       0        0        2        0        0        0     5      0.2
  C46        Kaposi\'s sarcoma              4     10      30       34       15       19       8        13    133    5.0
  C49        Other soft tissue              0     3       2        0        2        3        0        4     14     0.5
  C50        Breast                         5     0       17       127      215      196      99       70    729    27.1
  C51        Vulva                          0     3       1        3        2        2        5        4     20     0.7
  C52        Vagina                         0     4       2        6        2        3        6        4     27     1.0
  C53        Cervix                         1     0       5        32       77       90       56       41    302    11.2
  C54        Uterus                         2     1       4        5        15       31       28       26    112    4.2
  C56        Ovary                          1     17      21       16       19       29       16       13    132    4.9
  C57        Fallopian tube                 1     0       0        0        2        0        0        0     3      0.1
  C58        Placenta                       0     0       8        17       10       5        3        0     43     1.6
  C64        Kidney                         0     8       1        4        3        1        1        4     22     0.8
  C65        Renal pelvis                   0     0       0        0        0        0        0        1     1      0.0
  C67        Bladder                        0     0       1        2        7        4        5        2     21     0.8
  C69        Eye                            1     14      6        14       12       5        4        6     62     2.3
  C70--C72   Brain, nervous system          0     2       0        0        0        1        0        1     4      0.1
  C73        Thyroid                        1     0       14       8        12       14       10       3     62     2.3
  C76        Other and unspecified          0     0       1        2        2        2        0        2     9      0.3
  C77--C80   Metastasis                     0     1       0        8        10       12       9        1     41     1.5
  C81        Hodgkin disease                0     6       1        9        6        5        1        2     30     1.1
  C82--C85   Non-Hodgkin Lymphoma           2     36      38       33       19       16       14       12    170    6.3
  C90        Myeloma                        0     0       0        0        0        1        0        0     1      0.0
  C91--C95   Leukaemia                      0     1       9        7        5        2        3        2     29     1.1
                                                                                                                    
             All sites                      24    146     216      422      541      565      384      388   2686   100

###### 

Distribution of cancers by histological nature.

  Histological group                                         Histological type      Nb\*\* of cases   \%
  ---------------------------------------------------------- ---------------------- ----------------- ------
  Carcinomas 3574 cases; 68,1%                               Adenocarcinomas        2099              40.0
  Squamous cell carcinoma                                    1238                   23.6              
  Carcinoma NOS\*                                            155                    2.9               
  Urothelial carcinoma                                       35                     0.6               
  Medullar carcino ma                                        31                     0.6               
  Basaloid carcinoma                                         19                     0.4               
  Hematopoietic tissue Cancers 833 cases; 15.9%              Non-hodgkin lymphoma   663               12.6
  Hodgkin disease                                            97                     1.9               
  Leukaemia                                                  58                     1.1               
  Myeloma                                                    15                     0.3               
  Sarcomas 581 cases; 11.0%                                  Kaposi sarcoma         225               4.3
  Fibrosarcoma                                               146                    2.8               
  Leiomyosarcoma                                             38                     0.7               
  Rhabdomyosarcoma                                           35                     0.6               
  Osteosarcoma                                               30                     0.5               
  Chondrosarcoma                                             28                     0.5               
  Liposarcoma                                                27                     0.5               
  Angiosarcoma                                               19                     0.4               
  Malignant fibrous histiocytoma                             19                     0.4               
  Ewing sarcoma                                              4                      0.1               
  Sarcoma NOS\*                                              10                     0.2               
  Embryonic and placental malignant tumors 143 cases; 2.7%   Choriocarcinoma        50                1.0
  Retinoblastoma                                             38                     0.7               
  Wilms tumor                                                19                     0.4               
  Malignant teratoma                                         10                     0.2               
  Yolk sac tumor                                             6                      0.1               
  Hepatoblastoma                                             5                      0.1               
  Seminoma                                                   5                      0.1               
  Glioblastoma                                               5                      0.1               
  Gonadoblastoma                                             3                      0.0               
  Other                                                      2                      0.0               
  Other specified cancers 120 cases; 2.3%                    Melanoma               83                1.6
  Granulosa tumor                                            19                     0.4               
  Mesothelioma                                               7                      0.1               
  Malignant schwannoma                                       8                      0.2               
  Carcinosarcoma                                             3                      0.0               
                                                                                                      
                                                             All                    5251              100

\*NOS: not otherwise specified. \*\*Nb: Nomber.
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